Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

A companion animal primarily refers to cats and dogs, which are domesticated and normally maintained in or near the household of the owner or person caring for them. Pet or companion animals do not refer to a farm animal, or grazing animals such as cattle and sheep.

Statistics:

The global companion animal drugs market is estimated to account for US$ 49,244.3 Mn in terms of value by the end of 2027.

Global Companion Animal Drugs Market: Drivers

Increasing adoption of companion animals is expected to propel growth of the global companion animal drugs market over the forecast period. For instance, according to 2017-2018 U.S. Pet Ownership & Demographics Sourcebook of American Veterinary Medical Foundation (AVMF), 38.4% of household in the U.S. owned dogs compared to 36.5% in 2012.

Moreover, increasing geriatric population is also expected to boost is demand for companion animal drugs. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.     

 Statistics:

North America held dominant position in the global companion animal drugs market in 2019, accounting for 32.0% share in terms of value, followed by Europe and Asia Pacific, respectively.

Figure 1: Global Companion Animal Drugs Market, Regional Market Share Analysis, (%) 2019

Companion Animals Drug  | Coherent Market Insights

Global Companion Animal Drugs Market: Restraints

High cost of animal healthcare services and lack of pet insurance is expected to hinder growth of the global companion animal drugs market. For instance the companion animal healthcare expenses include annual surgical vet visits costs of US$ 474 for dogs, US$ 245 for cats, and US$ 45 for birds, sick vet visits costs (yearly average) of US$ 204 for dogs, US$ 244 for cats, and US$ 138 for birds, and emergency vet visits costs (yearly average) of US$ 349 for dogs, US$ 154 for cats, US$ 107 for birds, and US$ 471 for horses.

Moreover, lack of awareness of animal diseases is also expected to limit the demand for companion animal drugs. In many developing countries, people lack awareness regarding certain serious companion animal diseases as opposed to livestock diseases, which are more regularly monitored.

request-sample

Companion Animal Drugs Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 34,248.4 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 5.3% 2027 Value Projection: US$ 49,244.3 Mn
Geographies covered:
  • North America: U.S., Canada
  • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
  • Europe: Germany, U.K., France, Spain, Italy, Russia, Rest of Europe
  • Asia Pacific: China, Japan, India, Australia, South Korea, ASEAN, Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, Rest of Middle East
  • Africa: North Africa, Central Africa, South Africa
Segments covered:
  • By Product Type: Antibiotics, Anti-inflammatory, Parasiticides, Ecto-Parasiticides, Endo-Parasiticides, Heart worm Products, Behavioral Products, Nutritional Products, Skin care Products, Vaccines.
  • By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies and Drug Stores.
Companies covered:

Zoetis Inc., Merck & Co., Inc., Bayer AG, Eli Lily & Co., Sanofi (Merial), Ceva Santé Animal, Virbac Animal Health, and Boehringer Ingelheim GmbH

Growth Drivers:
  • Increasing prevalence of zoonotic diseases
  • Approval and launch of new products
Restraints & Challenges:
  • High cost of animal healthcare

Global Companion Animal Drugs Market: Opportunities 

High prevalence of salmonella infection is expected to offer lucrative growth opportunities for players in the global companion animal drugs market. For instance, according to May 2019 report of the Centers of Disease Control and Prevention (CDC), salmonella infection (salmonellosis) causes approximately 1.2 million illnesses and 450 deaths annually, in the U.S. and in 2018, there were 18 reported outbreaks, 15 of which were linked to food.

Moreover, availability of online veterinary pharmacies is also expected to aid in growth of the market.

Statistics:

The global companion animal drugs market was valued at US$ 34,248.4 Mn in 2020 and is forecast to reach a value of US$ 49,244.3 Mn by 2027 at a CAGR of 5.3% between 2020 and 2027.

Figure 2: Global Companion Animal Drugs Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Companion Animals Drug  | Coherent Market Insights

Market Trends/Key Takeaways

Approval for budget for equine health management is expected to propel growth of the global companion animal drugs market. For instance, in July 2020, the U.S. house passed Wild Horse Protection Amendment that directs the Bureau of Land Management to use at least US$ 11 million of its annual operating budget for its Wild Horse and Burro Program on the humane and proven safe fertility control vaccine, PZP.

Low equine vaccination is expected to hinder growth of the global companion animal drugs market. For instance, according to the U.S. Department of Agriculture’s August 2018 report, the percentage of operations that vaccinated any resident equids during the 12 months prior to the initial study survey was lower in 2015 than in 1998 and 2005.

Global Companion Animal Drugs Market: Competitive Landscape

Major players operating in the global companion animal drugs market include, Zoetis Inc., Merck & Co., Inc., Bayer AG, Eli Lily & Co., Sanofi (Merial), Ceva Santé Animal, Virbac Animal Health, and Boehringer Ingelheim GmbH.

Global Companion Animal Drugs Market: Key Developments

Major players in the global companion animal drugs market are focused on launching new products to expand their product portfolio. For instance, in 2018, Dechra Veterinary Products, LLC launched new TAF Spray, a next generation antibiotic wound spray used for the treatment of wounds in animals.

Similarly, in August 2018, Merial (Boehringer Ingelheim GmbH), received approval from the U.S Food and Drug Administration (FDA) to expand the label claims for NexGard (afoxolaner). NexGard can now be used to prevent Borrelia burgdorferi infections and Lyme disease in dogs.

Companion animal include dog, cat, fish, bird, horse, rabbit, hamster, guinea pig, and ferret. Companion animals are used for company, amusement, psychological support, extrovert display and all of the other functions that humans need to share with animals of other species. Increasing adoption of companion animals is expected to propel growth of the global companion animal drugs market over the forecast period. Furthermore, high prevalence of salmonella infection, along with increasing animal healthcare expenditure is also anticipated to assist the market growth during the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the Global Companion Animal Drugs market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Companion Animal Drugs market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Zoetis Inc., Merck & Co., Inc., Bayer AG, Eli Lily & Co., Sanofi (Merial), Ceva Santé Animal, Virbac Animal Health, and Boehringer Ingelheim GmbH
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Companion Animal Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Companion Animal Drugs market

Detailed Segmentation:

  • Global Companion Animal Drugs Market, By Product Type:
    • Antibiotics
    • Anti-inflammatory
    • Parasiticides
    • Ecto-Parasiticides
    • Endo-Parasiticides
    • Heart worm Products
    • Behavioral Products
    • Nutritional Products
    • Skin care Products
    • Vaccines
  • Global Companion Animal Drugs Market, By Distribution Channel:
    • Veterinary Hospitals
    • Veterinary Clinics
    • Pharmacies and Drug Stores
  • Global Companion Animal Drugs Market, By Region:
    • North America
      • By Product Type:
        • Antibiotics
        • Anti-inflammatory
        • Parasiticides
        • Ecto-Parasiticides
        • Endo-Parasiticides
        • Heart worm Products
        • Behavioral Products
        • Nutritional Products
        • Skin care Products
        • Vaccines
      • By Distribution Channel
        • Veterinary Hospitals
        • Veterinary Clinics
        • Pharmacies and Drug Stores
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Antibiotics
        • Anti-inflammatory
        • Parasiticides
        • Ecto-Parasiticides
        • Endo-Parasiticides
        • Heart worm Products
        • Behavioral Products
        • Nutritional Products
        • Skin care Products
        • Vaccines
      • By Distribution Channel
        • Veterinary Hospitals
        • Veterinary Clinics
        • Pharmacies and Drug Stores
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Antibiotics
        • Anti-inflammatory
        • Parasiticides
        • Ecto-Parasiticides
        • Endo-Parasiticides
        • Heart worm Products
        • Behavioral Products
        • Nutritional Products
        • Skin care Products
        • Vaccines
      • By Distribution Channel
        • Veterinary Hospitals
        • Veterinary Clinics
        • Pharmacies and Drug Stores
      • By Country
        • U.K.
        • Germany
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Antibiotics
        • Anti-inflammatory
        • Parasiticides
        • Ecto-Parasiticides
        • Endo-Parasiticides
        • Heart worm Products
        • Behavioral Products
        • Nutritional Products
        • Skin care Products
        • Vaccines
      • By Distribution Channel
        • Veterinary Hospitals
        • Veterinary Clinics
        • Pharmacies and Drug Stores
      • By Country
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Antibiotics
        • Anti-inflammatory
        • Parasiticides
        • Ecto-Parasiticides
        • Endo-Parasiticides
        • Heart worm Products
        • Behavioral Products
        • Nutritional Products
        • Skin care Products
        • Vaccines
      • By Distribution Channel
        • Veterinary Hospitals
        • Veterinary Clinics
        • Pharmacies and Drug Stores
      • By Country
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Antibiotics
        • Anti-inflammatory
        • Parasiticides
        • Ecto-Parasiticides
        • Endo-Parasiticides
        • Heart worm Products
        • Behavioral Products
        • Nutritional Products
        • Skin care Products
        • Vaccines
      • By Distribution Channel
        • Veterinary Hospitals
        • Veterinary Clinics
        • Pharmacies and Drug Stores
      • By Country
        • North Africa
        • Central Africa
        • South Africa
  • Company Profiles
    • Zoetis Inc. *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Merck & Co., Inc.
    • Bayer AG
    • Eli Lily & Co.
    • Sanofi (Merial)
    • Ceva Santé Animal
    • Virbac Animal Health
    • Boehringer Ingelheim GmbH
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • PEST Analysis
    • Technological Advancements
    • Regulatory Scenario
    • Mergers and Acquisitions
    • Impact of COVID19 on market
  4. Global Companion Animal Drugs Market, By Product Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Antibiotics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Anti-inflammatory
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Parasiticides
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Ecto-Parasiticides
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Endo-Parasiticides
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Heart worm Products
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Behavioral Products
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Nutritional Products
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Skin care Products
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global Companion Animal Drugs Market, By Distribution Channel, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Veterinary Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Veterinary Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Pharmacies and Drug Stores
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Companion Animal Drugs Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape
    • Company Profiles
      • Zoetis Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Merck & Co., Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bayer AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Eli Lily & Co.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sanofi (Merial)
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Ceva Santé Animal
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Virbac Animal Health
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Boehringer Ingelheim GmbH
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 22 market data tables and 14 figures on “Companion Animal Drugs Market - Global forecast to 2027”.

Frequently Asked Questions

The Global Companion Animal Drugs market size was estimated at US$ 34,248.4 million in 2020 and is anticipated to exhibit a CAGR of 5.3% between 2020 and 2027.
Ecto-Parasiticides segment held the major market share in 2019 owing to an and increasing product approvals is expected to propel growth of the market.
Major factor driving the growth of Global Companion Animal Drugs market during the forecast period increasing prevalence of zoonotic diseases, increasing research & development , and adoption of expansion strategies from major companies.
Major factors hampering the growth of the Global Companion Animal Drugs market during the forecast period constitutes of high cost of animal healthcare.
North America market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Zoetis Inc., Merck & Co., Inc., Bayer AG, Eli Lily & Co., Sanofi (Merial), Ceva Santé Animal, Virbac Animal Health, and Boehringer Ingelheim GmbH
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner